

Cover Story
Clinical
In an industry that set its sights on reshaping cancer detection, GRAIL Inc. had the appearance of a pioneer.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- Montefiore Einstein Director Edward Chu dies of glioblastoma at 66
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- Tidmarsh is out, Pazdur is in: FDA’s CDER under new leadership
- Mary Pazdur, 63, Dies of Cancer; What Her Husband Has Learned














